People with high insulin resistance (ie, people with obesity), young age at dysglycaemia, abnormal 1 h glucose concentrations (86 mmol/L) despite normal 2 hr glucose concentrations on 75 g oral glucose tolerance test, and low C-peptide are at higher risk for progressing to stage 3 (fast progressor, stage 2b) than those diagnosed with dysglycaemia after age 65 years (slow progressor, stage 2a)
Did Lilly Adjust the Dosing Strategy Whats interesting here is that, based on the above comments from Lilly, the expected weight loss for both diabetic patients with obesity and non-diabetic individuals with obesity doesnt seem to significantly surpass the results from phase two trials, which were conducted over shorter study periods
The English singer enjoyed a tropical getaway in Anguilla with fellow Brits Harry Styles and James Corden beginning on Friday, January 3 but it wasnt just her being spotted with her famous male pals that caught fans attention
"Orforglipron's oral delivery method could justify premium pricing, but Eli Lilly will likely prioritize market share over maximum margins in the competitive GLP-1 space ." Pharmaceutical Industry Analysis, 2024 How do pharmaceutical companies determine pricing strategies